![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
Mostafa Faisal
@MostafaFaisal14
Associate professor of Adult Hematology and BMT
ID:973249906977669120
12-03-2018 17:30:34
3,1K Tweets
443 Followers
854 Following
![Benlazar S M A(@smbenlazar) 's Twitter Profile Photo Benlazar S M A(@smbenlazar) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1683164907242487809/vhXwgzAz_200x200.jpg)
![Al-Ola A Abdallah MD (USMIRC)(@Abdallah81MD) 's Twitter Profile Photo Al-Ola A Abdallah MD (USMIRC)(@Abdallah81MD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1026948048264589312/U7U536oH_200x200.jpg)
Autologous-allogeneic vs autologous tandem SCT w thalidomide for MM Pts: a prospective, phase II study
-PFS at 4 years after the second transplant was 47% (95% CI: 38-55%) for alloTSCT and 35% for autoTSCT! -No OS benefit
#mmsm #myeloma #MedEd #Medtiwitter #USMIRC USMIRC News
![Al-Ola A Abdallah MD (USMIRC) (@Abdallah81MD) on Twitter photo 2024-05-14 05:46:14 Autologous-allogeneic vs autologous tandem SCT w thalidomide for MM Pts: a prospective, phase II study -PFS at 4 years after the second transplant was 47% (95% CI: 38-55%) for alloTSCT and 35% for autoTSCT! -No OS benefit #mmsm #myeloma #MedEd #Medtiwitter #USMIRC @USMIRCNEWS Autologous-allogeneic vs autologous tandem SCT w thalidomide for MM Pts: a prospective, phase II study -PFS at 4 years after the second transplant was 47% (95% CI: 38-55%) for alloTSCT and 35% for autoTSCT! -No OS benefit #mmsm #myeloma #MedEd #Medtiwitter #USMIRC @USMIRCNEWS](https://pbs.twimg.com/media/GNhFhFWWQAArdHi.jpg)
![Transplantation and Cellular Therapy Journal(@ASTCT_Journal) 's Twitter Profile Photo Transplantation and Cellular Therapy Journal(@ASTCT_Journal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1391830452374212610/OOZJUdEu_200x200.png)
![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
![Aaron Goodman - “Papa Heme”(@AaronGoodman33) 's Twitter Profile Photo Aaron Goodman - “Papa Heme”(@AaronGoodman33) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1477139722795302912/jwDheYRC_200x200.jpg)
![William Aird(@WilliamAird4) 's Twitter Profile Photo William Aird(@WilliamAird4) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1424436346073063426/ZZyZYD45_200x200.jpg)
![Benlazar S M A(@smbenlazar) 's Twitter Profile Photo Benlazar S M A(@smbenlazar) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1683164907242487809/vhXwgzAz_200x200.jpg)
![Graham Collins(@graham74GC) 's Twitter Profile Photo Graham Collins(@graham74GC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1511385796925927431/Z7MlnQTW_200x200.jpg)
![Anand Patel(@Anand_88_Patel) 's Twitter Profile Photo Anand Patel(@Anand_88_Patel) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1407845630169473029/mriIjT6j_200x200.jpg)
Informative paper in Blood Journal re achievement of CRh with targeted therapies in AML!
ashpublications.org/blood/article/…
![Anand Patel (@Anand_88_Patel) on Twitter photo 2024-05-13 20:51:43 Informative paper in @BloodJournal re achievement of CRh with targeted therapies in AML! ashpublications.org/blood/article/… Informative paper in @BloodJournal re achievement of CRh with targeted therapies in AML! ashpublications.org/blood/article/…](https://pbs.twimg.com/media/GNfLJHFXAAAK5M0.jpg)
![Transplantation and Cellular Therapy Journal(@ASTCT_Journal) 's Twitter Profile Photo Transplantation and Cellular Therapy Journal(@ASTCT_Journal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1391830452374212610/OOZJUdEu_200x200.png)
![Blood Journal(@BloodJournal) 's Twitter Profile Photo Blood Journal(@BloodJournal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1478448682739638272/FSBB4QOL_200x200.png)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
Read our summary of a study published by Talha Badar comparing HMA + venetoclax with HMAs alone in adults with newly diagnosed TP53-mutated AML 👉 loom.ly/ZwBv1aM
#AMLsm #leusm #MedicalEducation
![AML Hub (@AML_Hub) on Twitter photo 2024-05-13 08:30:19 Read our summary of a study published by @TalhaBadarMD comparing HMA + venetoclax with HMAs alone in adults with newly diagnosed TP53-mutated AML 👉 loom.ly/ZwBv1aM #AMLsm #leusm #MedicalEducation Read our summary of a study published by @TalhaBadarMD comparing HMA + venetoclax with HMAs alone in adults with newly diagnosed TP53-mutated AML 👉 loom.ly/ZwBv1aM #AMLsm #leusm #MedicalEducation](https://pbs.twimg.com/media/GNchcmxWEAA-Dzg.jpg)
![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
Improved outcome of allogeneic transplantation in older patients treated for myeloid malignancies using post transplantation cyclophosphamide and reduced duration of immune suppression Transplantation and Cellular Therapy Journal
astctjournal.org/article/S2666-…
![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
Autologous hematopoietic cell transplantation consolidation for first response is associated with longer survival among patients with nodal peripheral T-cell lymphoma Transplantation and Cellular Therapy Journal
astctjournal.org/article/S2666-…
![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
The role of pre-existing anti-HLA antibodies in severe aplastic anemia patients undergoing allogenic hematopoietic stem cell Transplantation and Cellular Therapy Journal
astctjournal.org/article/S2666-…
![Benlazar S M A(@smbenlazar) 's Twitter Profile Photo Benlazar S M A(@smbenlazar) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1683164907242487809/vhXwgzAz_200x200.jpg)
![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
Ponatinib-review of historical development, current status, and future research AmericanJournalofHematology
onlinelibrary.wiley.com/doi/abs/10.100…
![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
How I manage iron overload in the hemopoietic cell transplantation setting Blood Journal
ashpublications.org/blood/article/…
![Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo Mostafa Faisal(@MostafaFaisal14) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1606311467124408321/PoIjbPJO_200x200.jpg)
How I Treat Challenging Transfusion Cases in Sickle Cell Disease Blood Journal
ashpublications.org/blood/article/…
![Rami komrokji(@Ramikomrokji) 's Twitter Profile Photo Rami komrokji(@Ramikomrokji) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/690654599456301056/zK8GvN24_200x200.jpg)
Honored to be co-senior author on this effort led by Dr Della Porta combining GenoMed and Moffitt database. Moffitt Cancer Center Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of AHSCT in Pts With MDS | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…